Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Brauch

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Klinische Monatsblatter Fur Augenheilkunde|March 1, 1997
[Hippel-Lindau syndrome. Clinical and genetic aspects of angiomatosis retinae]H Brauch
Deutsche Medizinische Wochenschrift (1946)|October 13, 1995
[Molecular diagnosis of the Hippel-Lindau syndrome]H P Neumann, H Brauch
Human Genetics|June 21, 2001
DHPLC-based germline mutation screening in the analysis of the VHL tumor suppressor gene: usefulness and limitationsB Klein, G Weirich, H Brauch
Immunobiology|August 1, 1983
Glycophorin A inhibits lysis by the complement attack phaseH Brauch, D Roelcke, U Rother
Der Pathologe|September 1, 1995
[Hippel-Lindau syndrome and sporadic renal cell carcinomas. Pathogenesis, morphologic spectrum and molecular genetics]H Brauch, J Böhm, H Höfler
Nature|June 1, 1987
Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinomaB Zbar, H Brauch, C Talmadge, et al.
Clinical Nephrology|May 29, 2009
Bilateral renal-cell carcinoma associated with an acquired VHL mutation and long-term trichloroethylene exposureG M Wells, W Schroth, H Brauch, et al.
Archives of Toxicology|January 1, 1997
Renal cell carcinomas in trichloroethene (TRI) exposed persons are associated with somatic mutations in the von Hippel-Lindau (VHL) tumour suppressor geneT Brüning, G Weirich, M A Hornauer, et al.
Molecular Biotechnology|January 23, 1998
Fixed archival tissue. Purify DNA and primers for good PCR yield!G Weirich, M A Hornauer, T Brüning, et al.
Deutsche Medizinische Wochenschrift (1946)|March 3, 2011
[Pharmacogenomics: hype or hope?]M Schwab, E Schaeffeler, U M Zanger, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Klinische Monatsblatter Fur Augenheilkunde|March 1, 1997
[Hippel-Lindau syndrome. Clinical and genetic aspects of angiomatosis retinae]H Brauch
Deutsche Medizinische Wochenschrift (1946)|October 13, 1995
[Molecular diagnosis of the Hippel-Lindau syndrome]H P Neumann, H Brauch
Human Genetics|June 21, 2001
DHPLC-based germline mutation screening in the analysis of the VHL tumor suppressor gene: usefulness and limitationsB Klein, G Weirich, H Brauch
Immunobiology|August 1, 1983
Glycophorin A inhibits lysis by the complement attack phaseH Brauch, D Roelcke, U Rother
Der Pathologe|September 1, 1995
[Hippel-Lindau syndrome and sporadic renal cell carcinomas. Pathogenesis, morphologic spectrum and molecular genetics]H Brauch, J Böhm, H Höfler
Nature|June 1, 1987
Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinomaB Zbar, H Brauch, C Talmadge, et al.
Clinical Nephrology|May 29, 2009
Bilateral renal-cell carcinoma associated with an acquired VHL mutation and long-term trichloroethylene exposureG M Wells, W Schroth, H Brauch, et al.
Archives of Toxicology|January 1, 1997
Renal cell carcinomas in trichloroethene (TRI) exposed persons are associated with somatic mutations in the von Hippel-Lindau (VHL) tumour suppressor geneT Brüning, G Weirich, M A Hornauer, et al.
Molecular Biotechnology|January 23, 1998
Fixed archival tissue. Purify DNA and primers for good PCR yield!G Weirich, M A Hornauer, T Brüning, et al.
Deutsche Medizinische Wochenschrift (1946)|March 3, 2011
[Pharmacogenomics: hype or hope?]M Schwab, E Schaeffeler, U M Zanger, et al.
Pageof 8